---
title: "BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | BGLC Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278724397.md"
description: "BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | BGLC Stock News"
datetime: "2026-03-11T04:45:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278724397.md)
  - [en](https://longbridge.com/en/news/278724397.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278724397.md)
generator: "portal-rs"
---

# BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | BGLC Stock News

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform | BGLC Stock News

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [BGLC.US](https://longbridge.com/en/quote/BGLC.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Bank OZK (OZK) Plans North Carolina Expansion, Is The Stock Still Cheap?](https://longbridge.com/en/news/298010330.md)
- [Tango Therapeutics (TNGX) Stock Looks Stretched After Its 236% Run](https://longbridge.com/en/news/297812050.md)
- [Is Kura Oncology's (KURA) Zacks Upgrade Quietly Reframing Its Precision Oncology Risk‑Reward Story?](https://longbridge.com/en/news/297754554.md)
- [Braidwell LP Invests $34.02 Million in Maze Therapeutics, Inc. $MAZE](https://longbridge.com/en/news/297882633.md)
- [INmune Bio (NASDAQ:INMB) Stock Price Down 1.3%  - What's Next?](https://longbridge.com/en/news/297595042.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**